286 related articles for article (PubMed ID: 15585783)
1. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
Bouhnik Y; Raskine L; Simoneau G; Vicaut E; Neut C; Flourié B; Brouns F; Bornet FR
Am J Clin Nutr; 2004 Dec; 80(6):1658-64. PubMed ID: 15585783
[TBL] [Abstract][Full Text] [Related]
2. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans.
Bouhnik Y; Raskine L; Simoneau G; Paineau D; Bornet F
Nutr J; 2006 Mar; 5():8. PubMed ID: 16569219
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans.
Kolida S; Meyer D; Gibson GR
Eur J Clin Nutr; 2007 Oct; 61(10):1189-95. PubMed ID: 17268410
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.
Bouhnik Y; Vahedi K; Achour L; Attar A; Salfati J; Pochart P; Marteau P; Flourié B; Bornet F; Rambaud JC
J Nutr; 1999 Jan; 129(1):113-6. PubMed ID: 9915885
[TBL] [Abstract][Full Text] [Related]
5. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants.
Moro G; Minoli I; Mosca M; Fanaro S; Jelinek J; Stahl B; Boehm G
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):291-5. PubMed ID: 11964956
[TBL] [Abstract][Full Text] [Related]
6. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study.
Depeint F; Tzortzis G; Vulevic J; I'anson K; Gibson GR
Am J Clin Nutr; 2008 Mar; 87(3):785-91. PubMed ID: 18326619
[TBL] [Abstract][Full Text] [Related]
7. In healthy adults, resistant maltodextrin produces a greater change in fecal bifidobacteria counts and increases stool wet weight: a double-blind, randomized, controlled crossover study.
Burns AM; Solch RJ; Dennis-Wall JC; Ukhanova M; Nieves C; Mai V; Christman MC; Gordon DT; Langkamp-Henken B
Nutr Res; 2018 Dec; 60():33-42. PubMed ID: 30527258
[TBL] [Abstract][Full Text] [Related]
8. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.
Bouhnik Y; Attar A; Joly FA; Riottot M; Dyard F; Flourié B
Eur J Clin Nutr; 2004 Mar; 58(3):462-6. PubMed ID: 14985684
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects.
Costabile A; Kolida S; Klinder A; Gietl E; Bäuerlein M; Frohberg C; Landschütze V; Gibson GR
Br J Nutr; 2010 Oct; 104(7):1007-17. PubMed ID: 20591206
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers.
Vulevic J; Drakoularakou A; Yaqoob P; Tzortzis G; Gibson GR
Am J Clin Nutr; 2008 Nov; 88(5):1438-46. PubMed ID: 18996881
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial.
Chen HL; Cheng HC; Wu WT; Liu YJ; Liu SY
J Am Coll Nutr; 2008 Feb; 27(1):102-8. PubMed ID: 18460488
[TBL] [Abstract][Full Text] [Related]
12. Dose-response effects of inulin and oligofructose on intestinal bifidogenesis effects.
Rao AV
J Nutr; 1999 Jul; 129(7 Suppl):1442S-5S. PubMed ID: 10395617
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture.
Gibson GR; Wang X
FEMS Microbiol Lett; 1994 May; 118(1-2):121-7. PubMed ID: 8013867
[TBL] [Abstract][Full Text] [Related]
14. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures.
Rossi M; Corradini C; Amaretti A; Nicolini M; Pompei A; Zanoni S; Matteuzzi D
Appl Environ Microbiol; 2005 Oct; 71(10):6150-8. PubMed ID: 16204533
[TBL] [Abstract][Full Text] [Related]
15. Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans.
Bouhnik Y; Flourie B; Andrieux C; Bisetti N; Briet F; Rambaud JC
Eur J Clin Nutr; 1996 Apr; 50(4):269-73. PubMed ID: 8730616
[TBL] [Abstract][Full Text] [Related]
16. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.
Bouhnik Y; Achour L; Paineau D; Riottot M; Attar A; Bornet F
Nutr J; 2007 Dec; 6():42. PubMed ID: 18053236
[TBL] [Abstract][Full Text] [Related]
17. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans.
Bouhnik Y; Flourié B; D'Agay-Abensour L; Pochart P; Gramet G; Durand M; Rambaud JC
J Nutr; 1997 Mar; 127(3):444-8. PubMed ID: 9082028
[TBL] [Abstract][Full Text] [Related]
18. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
19. Relationship of prebiotics and food to intestinal microflora.
Blaut M
Eur J Nutr; 2002 Nov; 41 Suppl 1():I11-6. PubMed ID: 12420111
[TBL] [Abstract][Full Text] [Related]
20. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study.
Fanaro S; Marten B; Bagna R; Vigi V; Fabris C; Peña-Quintana L; Argüelles F; Scholz-Ahrens KE; Sawatzki G; Zelenka R; Schrezenmeir J; de Vrese M; Bertino E
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):82-8. PubMed ID: 19172129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
